# Chemoreflex and Baroreflex Alterations Causing Postural Tachycardia Syndrome With Orthostatic Hyperpnea and Hypocapnia

> **NCT05923840** · NA · UNKNOWN · sponsor: **New York Medical College** · enrollment: 30 (estimated)

## Conditions studied

- Postural Orthostatic Tachycardia Syndrome
- Hypocapnia
- Hyperventilation

## Interventions

- **DIAGNOSTIC_TEST:** Chemoreflex Testing
- **DIAGNOSTIC_TEST:** Baroreflex testing
- **DIAGNOSTIC_TEST:** Orthostatic stress testing

## Key facts

- **NCT ID:** NCT05923840
- **Lead sponsor:** New York Medical College
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-09-23
- **Primary completion:** 2023-08-31
- **Final completion:** 2024-08-31
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2023-06-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05923840

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05923840, "Chemoreflex and Baroreflex Alterations Causing Postural Tachycardia Syndrome With Orthostatic Hyperpnea and Hypocapnia". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05923840. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*